The first drug to treat a lack of female sexual desire has been approved by federal authorities.

The drug flibanserin, which has been coined ‘female Viagra,’ is intended to treat women with a condition called hypoactive sexual desire disorder (HSDD) that’s characterized by lagging libido. On Tuesday, the drug was approved by the U.S. Food and Drug Administration. “Today’s approval provides women distressed by their low sexual desire with an approved treatment option,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.

Although the drug is being called a “Viagra” for women, it actually works quite differently. You can see how below.

Heather Jones for TIME

Read next: What 8 Medical Experts Think About ‘Female Viagra’

Download TIME’s mobile app for iOS to have your world explained wherever you go

Get our Health Newsletter. Sign up to receive the latest health and science news, plus answers to wellness questions and expert tips. Please enter a valid email address. Sign Up Now Check the box if you do not wish to receive promotional offers via email from TIME. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you! For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

Contact us at letters@time.com.